CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 182 enrolled
Drug / intervention
Mindfulness-Based Relapse Prevention Therapy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02994043
NCT02994043N/ACompleted
CompareCT.gov

Dismantling MBRP: Identifying Critical Neuroimmune Mechanisms of Action.

University of Colorado, Denver·interventional·Posted Dec 15, 2016·Updated Jan 19, 2023

In Brief

A clinical study evaluating Mindfulness-Based Relapse Prevention Therapy and Relapse Prevention Therapy for Alcohol Use Disorder. Completed, enrolled 182 participants across 1 site.

Detailed Summary

The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteristics of AUD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder
CountriesUnited States
CollaboratorsUniversity of Colorado, Boulder, National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 15, 2016
Enrollment StartNov 9, 2016
Primary CompletionFeb 17, 2021
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 9.5 years ago

Interventions

Mindfulness-Based Relapse Prevention Therapybehavioral

An 8-week, outpatient psychotherapy that combines mindfulness components with relapse prevention.

Relapse Prevention Therapybehavioral

An 8-week, outpatient psychotherapy that uses cognitive-behavioral components to reduce alcohol-related consequences.